Order Article Reprints

Tsakaldimis G, Diamantidis D, Lailisidis S, Kafalis C, Panagiotopoulos N, Georgellis C, Giannopoulos S, Chousein C, Spounos M, Deligeorgiou E, et al. Evaluating the Diagnostic Role of the Testosterone-to-Prostate-Specific Antigen Ratio in Pre-Biopsy Risk Stratification of Prostate Cancer. Journal of Clinical Medicine. 2025; 14(9):3022. https://doi.org/10.3390/jcm14093022

Tsakaldimis, Georgios, Dimitrios Diamantidis, Stavros Lailisidis, Charalampos Kafalis, Nikolaos Panagiotopoulos, Chrysostomos Georgellis, Stavros Giannopoulos, Chousein Chousein, Marios Spounos, Evangelia Deligeorgiou, and et al. 2025. "Evaluating the Diagnostic Role of the Testosterone-to-Prostate-Specific Antigen Ratio in Pre-Biopsy Risk Stratification of Prostate Cancer" Journal of Clinical Medicine 14, no. 9: 3022. https://doi.org/10.3390/jcm14093022

Tsakaldimis, G., Diamantidis, D., Lailisidis, S., Kafalis, C., Panagiotopoulos, N., Georgellis, C., Giannopoulos, S., Chousein, C., Spounos, M., Deligeorgiou, E., Giannakopoulos, S., & Kalaitzis, C. (2025). Evaluating the Diagnostic Role of the Testosterone-to-Prostate-Specific Antigen Ratio in Pre-Biopsy Risk Stratification of Prostate Cancer. Journal of Clinical Medicine, 14(9), 3022. https://doi.org/10.3390/jcm14093022